Trademark: MYRISK HEREDITARY CANCER TEST
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
MYRISK HEREDITARY CANCER TEST
Click here to search for trademarks similar to MYRISK HEREDITARY CANCER TEST
Proof of use for MYRISK HEREDITARY CANCER TEST
We do not have any records of a proof of use for MYRISK HEREDITARY CANCER TEST at this moment.
Click here to add a proof of use for MYRISK HEREDITARY CANCER TEST
Possible trademark infringements of MYRISK HEREDITARY CANCER TEST
Basic Information about MYRISK HEREDITARY CANCER TEST
- Serial Number
- 99006549
- Filing Date
- 17 Jan 2025
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of MYRISK HEREDITARY CANCER TEST on the blockchain with WikiTrademarks.io.
- First use of MYRISK HEREDITARY CANCER TEST anywhere
- MYRISK HEREDITARY CANCER TEST was first used on 05 Nov 2021 for the primary classification of goods and services, international, 010 (Medical Apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
Who owns MYRISK HEREDITARY CANCER TEST?
1. Myriad Genetics, Inc. Salt Lake City UT
Correspondent
- Katherine P. Califa Foley & Lardner LLP
- 3000 K Street, N.W.
- Sixth Floor
- Washington, DC 20007
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io